BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), announced that Dr. Thomas Broudy has been appointed as Chief Executive Officer to lead the company's growth of its biologic drug substance and sterile drug product development and manufacturing services. "BioCina is entering…
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced key additions to its executive leadership team. These appointments reflect the company's continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The boa…
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced executive appointments aimed at strengthening global operations and accelerating strategic growth across Diagnostics and Life Science. Andy Kitzmiller Appointed President and Chief Executive …
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Gregory L. Summe, current independent director, will serve as the Company's next Chairman of the Board, beginning January 1, 2026. Jonathan Peacock has…
Biomerics, a leading vertically integrated contract manufacturer for the interventional medical device market, announced the appointment of Arun Mohan as Chief Executive Officer. Founder and current CEO Travis Sessions will transition into the role of Chairman of the Board, ensuring continuity in vision and strategy.…
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, announced expansion of the company's leadership team including the promotion of Michael Yeh, M.D. to Chief Medical Officer and the appointment of Ian Vawter as Chief Financial Officer…
Astellas Pharma Inc. announced the following changes to its Top Management structure, effective October 1, 2025. Nick Eshkenazi, current Chief Digital & Transformation Officer (CDTO), will leave Astellas on September 30, 2025. Consequently, effective October 1, 2025, the position of CDTO will be removed from Top…
Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), announced the appointment of Kenneth Bilenberg as its new Chief Executive Officer (CEO). A seasoned industry executive with more than 20 years of experience, Bilenberg most recently served as Chief Operating Officer…
Lonza announced that its Board of Directors has approved the appointment of Jason Berndt as Head of Group Operations, Executive Vice President and member of the EC. Jason succeeds Maria Soler Nunez, who will take up the newly-created role of Chief Quality Officer and Executive Vice President, remaining a member of the…
Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO), announced a strategic addition to its executive team to accelerate its long-term growth objectives, strengthen leadership, and enhance collaboration across the company. Bob Rodebaugh has been promoted to Vice Pres…
Page 9 of 15